CONMED Corp — Director's Dealing 2016

Jan 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-01-04

Reporting Person: Farkas Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	Common Stock	P	332	$42.1829	Acquired	4064	Direct

Footnotes

F1: The purchase reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/27/15.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.18 to $42.26. Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.